Inmune Bio Inc (INMB)

R&D Expense Growth

-77.95%

Quarterly · Period ending:

INMB logo

INMB R&D Expense Growth

Latest reported-77.95%
INMB Quarterly R&D Growth (QoQ) (0.00% → -77.95%)
High-resolution chart · PNG

INMB r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Inmune Bio Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-77.9456%
56.3332%
-52.343%
-15.7994%
-24.0215%
3.8896%
-26.9594%
42.7336%
-18.8658%
44.7145%
0.3676%
44.2864%
0.3629%
21.2023%
-33.9019%
23.1559%
-2.7849%
-39.0351%
8.4049%
46.0573%
79.2051%
33.9968%
-21.3288%
161.6708%
13.9074%
-8.5128%
-25.8086%
297.5331%
189.2078%
-80.2843%
159.2295%
-30.8162%
176.2362%
-61.2414%
479.3523%
-28.6726%
12.6844%
104.6084%
2.1803%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.